ZyVersa Therapeutics (ZVSA) Tops Q2 EPS by 44c

ZyVersa Therapeutics (NASDAQ: ZVSA) reported Q2 EPS of ($3.31), $0.44 better than the analyst estimate of ($3.75).

For earnings history and earnings-related data on ZyVersa Therapeutics (ZVSA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• HSBC Downgrades Stellantis NV (STLA:IM) (STLA) to Reduce
• Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform